Pharmacokinetics of netilmicin in premature infants
- 1 January 1986
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 29 (5) , 635-637
- https://doi.org/10.1007/bf00635907
Abstract
The pharmacokinetics of netilmicin were studied in 12 premature infants with proven or presumed sepsis during the first month of life. Eleven of 12 patients received netilmicin 2.5 mg/kg intravenously every 12 h while one 770-gram birth weight infant received 2.5 mg/kg every 18 h. Mean steady-state peak and trough concentrations were 8.9 µg/ml and 2.8 µg/ml, respectively. Of twelve patients, 11 had trough serum concentration above 2 µg/ml and four had trough serum concentrations above 3 µg/ml. Mean total body clearance of netilmicin was 0.84 ml/min/kg. The mean clearance of 0.72 ml/min/kg was substantially lower in patients with a mean postnatal age of 2.7 days than the clearance of 1.10 ml/min/kg in patients with a mean postnatal age of 23 days. The mean apparent volume of distribution was 0.63 l/kg; and the mean elimination half-life was 8.6 h. A three-fold interpatient variation in pharmacokinetic parameters was seen. These data suggest the need for careful monitoring of netilmicin serum concentration in premature infants.Keywords
This publication has 6 references indexed in Scilit:
- Clinical pharmacology of netilmicin in preterm and term newborn infantsThe Journal of Pediatrics, 1985
- Effect of infusion methods on tobramycin serum concentrations in newborn infantsThe Journal of Pediatrics, 1984
- Clinical pharmacology of netilmicin in the newborn.Archives of Disease in Childhood, 1983
- Pharmacokinetic assessment of Netilmicin in newborns and older childrenInfection, 1982
- Netilmicin in moderate to severe infections in newborns and infants: a study of efficacy, tolerance and pharmacokinetics.1980
- Pharmacokinetic Properties of Netilmicin in Newborn InfantsAntimicrobial Agents and Chemotherapy, 1979